Teva Pharmaceutical Industries Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of TEVJF for the last quarter is 4.71 B USD, and it's 25.72% higher compared to the previous quarter. The net income of Q4 23 is 486.33 M USD.